GT
GSK icon

Glenmede Trust’s GSK GSK Stock Holding History

Glenmede Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24
Closed -$15K – 1219
2020
Q4 		$15K Buy
+24
New +$1.1K ﹤0.01% 1159

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Glenmede Trust's GSK Position: Q1 2026 in Review

Glenmede Trust reduced its GSK (GSK) stake by 14% in Q1 2026, selling an estimated $408K and leaving 47,138 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #529.

Glenmede Trust first reported a position in GSK in Q2 2013 and has held it in 50 quarters since. The position peaked at $14.3M in Q3 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Glenmede Trust held 47,138 shares of GSK worth $2.6M as of Q1 2026.
  • Glenmede Trust sold 7,530 GSK shares in Q1 2026, an estimated $408K.
  • GSK made up 0.01% of Glenmede Trust's portfolio in Q1 2026, its #529 holding.
  • Glenmede Trust first reported a position in GSK in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's GSK position peaked at $14.3M in Q3 2016.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.